222 related articles for article (PubMed ID: 38795169)
1. Rescuing tri-heteromeric NMDA receptor function: the potential of pregnenolone-sulfate in loss-of-function GRIN2B variants.
Kellner S; Berlin S
Cell Mol Life Sci; 2024 May; 81(1):235. PubMed ID: 38795169
[TBL] [Abstract][Full Text] [Related]
2. Opportunities for Precision Treatment of
Han W; Yuan H; Allen JP; Kim S; Shaulsky GH; Perszyk RE; Traynelis SF; Myers SJ
J Pharmacol Exp Ther; 2022 Apr; 381(1):54-66. PubMed ID: 35110392
[TBL] [Abstract][Full Text] [Related]
3. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
[TBL] [Abstract][Full Text] [Related]
4. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
[TBL] [Abstract][Full Text] [Related]
5. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
Wilding TJ; Lopez MN; Huettner JE
J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
[TBL] [Abstract][Full Text] [Related]
6. Triclosan-Evoked Neurotoxicity Involves NMDAR Subunits with the Specific Role of GluN2A in Caspase-3-Dependent Apoptosis.
Szychowski KA; Wnuk A; Rzemieniec J; Kajta M; Leszczyńska T; Wójtowicz AK
Mol Neurobiol; 2019 Jan; 56(1):1-12. PubMed ID: 29675573
[TBL] [Abstract][Full Text] [Related]
7. A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.
Swanger SA; Vance KM; Acker TM; Zimmerman SS; DiRaddo JO; Myers SJ; Bundgaard C; Mosley CA; Summer SL; Menaldino DS; Jensen HS; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2018 Feb; 9(2):306-319. PubMed ID: 29043770
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mice carrying a neurodevelopmental disease-associated GluN2B(L825V) variant.
Candelas Serra M; Kuchtiak V; Kubik-Zahorodna A; Kysilov B; Fili K; Hrcka Krausova B; Abramova V; Dobrovolski M; Harant K; Bozikova P; Cerny J; Prochazka J; Kasparek P; Sedlacek R; Balik A; Smejkalova T; Vyklicky L
J Neurosci; 2024 Jun; ():. PubMed ID: 38926089
[No Abstract] [Full Text] [Related]
9. The GluN2B-Glu413Gly NMDA receptor variant arising from a de novo GRIN2B mutation promotes ligand-unbinding and domain opening.
Wells G; Yuan H; McDaniel MJ; Kusumoto H; Snyder JP; Liotta DC; Traynelis SF
Proteins; 2018 Dec; 86(12):1265-1276. PubMed ID: 30168177
[TBL] [Abstract][Full Text] [Related]
10. Two
Kellner S; Abbasi A; Carmi I; Heinrich R; Garin-Shkolnik T; Hershkovitz T; Giladi M; Haitin Y; Johannesen KM; Steensbjerre Møller R; Berlin S
Elife; 2021 Jul; 10():. PubMed ID: 34212862
[TBL] [Abstract][Full Text] [Related]
11. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M
Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999
[TBL] [Abstract][Full Text] [Related]
12. An alternating GluN1-2-1-2 subunit arrangement in mature NMDA receptors.
Riou M; Stroebel D; Edwardson JM; Paoletti P
PLoS One; 2012; 7(4):e35134. PubMed ID: 22493736
[TBL] [Abstract][Full Text] [Related]
13. Developmental Changes of Synaptic and Extrasynaptic NMDA Receptor Expression in Rat Cerebellar Neurons In Vitro.
Sibarov DA; Stepanenko YD; Silantiev IV; Abushik PA; Karelina TV; Antonov SM
J Mol Neurosci; 2018 Feb; 64(2):300-311. PubMed ID: 29285738
[TBL] [Abstract][Full Text] [Related]
14. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
Chen X; Keramidas A; Harvey RJ; Lynch JW
Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
[TBL] [Abstract][Full Text] [Related]
15. Pregnenolone sulfate activates NMDA receptor channels.
Adamusová E; Cais O; Vyklický V; Kudová E; Chodounská H; Horák M; Vyklický L
Physiol Res; 2013; 62(6):731-6. PubMed ID: 24359434
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.
Cheriyan J; Balsara RD; Hansen KB; Castellino FJ
Neurosci Lett; 2016 Mar; 617():240-6. PubMed ID: 26917100
[TBL] [Abstract][Full Text] [Related]
17. Analysis of M4 Transmembrane Segments in NMDA Receptor Function: A Negative Allosteric Modulatory Site at the GluN1 M4 is Determining the Efficiency of Neurosteroid Modulation.
Langer K; Müller-Längle A; Wempe J; Laube B
Front Pharmacol; 2021; 12():769046. PubMed ID: 34658899
[TBL] [Abstract][Full Text] [Related]
18. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
[TBL] [Abstract][Full Text] [Related]
19. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
Tang W; Liu D; Traynelis SF; Yuan H
Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]